| Literature DB >> 19643001 |
Betti Giusti1, Marina Marini, Luciana Rossi, Ilaria Lapini, Alberto Magi, Andrea Capalbo, Rosa Lapalombella, Simona di Tullio, Michele Samaja, Fabio Esposito, Vittoria Margonato, Maria Boddi, Rosanna Abbate, Arsenio Veicsteinas.
Abstract
BACKGROUND: Epidemiological studies showed that physical exercise, specifically moderate lifelong training, is protective against cardiovascular morbidity and mortality. Most experimental work has focused into the effects and molecular mechanisms underlying intense, rather than mild exercise, by exploring the acute effect of training. Our study aims at investigating the cardioprotective effect of mild chronic exercise training and the gene expression profile changes at 48 hrs after the exercise cessation. Rats were trained at mild intensity on a treadmill: 25 m/min, 10%incline, 1 h/day, 3 days/week, 10 weeks; about 60% of the maximum aerobic power. By Affymetrix technology, we investigated the gene expression profile induced by exercise training in the left ventricle (LV) of trained (n = 10) and control (n = 10) rats. Cardioprotection was investigated by ischemia/reperfusion experiments (n = 10 trained vs. n = 10 control rats).Entities:
Mesh:
Year: 2009 PMID: 19643001 PMCID: PMC2907697 DOI: 10.1186/1471-2164-10-342
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Animal characteristics.
| Control rats | Exercise-trained rats | p | |
|---|---|---|---|
| 10 | 10 | ||
| 588 (496–629) | 567 (519–613) | ns | |
| 1.41 (1.30–1.56) | 1.40 (1.23–1.60) | ns | |
| 2.46 (2.27–2.66) | 2.48 (2.34–2.80) | ns | |
| 4.16 (3.70–5.10) | 4.08 (3.55–5.02) | ns | |
| 0.95 (0.81–1.04) | 0.91 (0.84–1.47) | ns | |
| 0.38 (0.30–0.48) | 0.45 (0.40–0.51) | 0.002 |
LV/(RV+S) = Left ventricle/(right ventricle + septum) wall thickness. Data are expressed as median and range.
Differentially expressed genes between control (n = 10) and trained (n = 10) rat groups.
| Gene Name (Gene Symbol) | Gene ID | GenBank | Probe name | D | r |
|---|---|---|---|---|---|
| similar to C11orf17 protein (RGD1306959) | 361624 | 1392938_s_at | 5.039 | 1.5 | |
| caveolin 3 (Cav3) | 29161 | 1387814_at | 4.216 | 1.4 | |
| similar to RIKEN cDNA 1700012G19 gene (RGD1307773) | 287115 | 1388881_at | 4.206 | 1.2 | |
| similar to C11orf17 protein (RGD1306959) | 361624 | 1385458_a_at | 4.168 | 1.6 | |
| enolase 3, beta (Eno3) | 25438 | 1386907_at | 4.135 | 1.5 | |
| similar to C11orf17 protein (RGD1306959) | 361624 | 1383175_a_at | 3.947 | 1.5 | |
| cytochrome P450, family 27, subfamily a, polypeptide 1 (Cyp27a1) | 301517 | 1387914_at | 3.927 | 1.4 | |
| similar to RIKEN cDNA 2700002I20 (RGD1307279) | 307210 | 1373074_at | 3.783 | 1.3 | |
| EGL nine homolog 1 (Egln1) | 308913 | 1389207_at | 3.652 | 1.2 | |
| Unknown | NA | 1373167_at | 3.594 | 1.2 | |
| cystatin C (Cst3) | 25307 | 1370855_at | 3.457 | 1.3 | |
| tumor necrosis factor, alpha-induced protein 1 (endothelial) (Tnfaip1) | 287543 | 1371911_at | 3.433 | 1.2 | |
Probe name = Affymetrix number of the probe set that recognized the specific transcript; d = significance analysis of microarrays (SAM) t-statistic; r = fold change according to SAM [mean(TRA intensities)/mean(CTR intensities)].
Genes in the ARENRF2PATHWAY (Antioxidant Response Elements Nrf1 and Nrf2 pathway) and GABAPATHWAY (Gamma-AminoButyric Acid pathway).
| GENE NAME | GENE SYMBOL |
|---|---|
| cAMP responsive element binding protein 1 | Creb1 |
| FBJ murine osteosarcoma viral oncogene homolog | Fos |
| FXYD domain-containing ion transport regulator 2 | Fxyd2 |
| Jun oncogene | Jun |
| Kelch-like ECH-associated protein 1 | Keap1 |
| mitogen activated protein kinase 1 | Mapk1 |
| mitogen activated protein kinase 14 | Mapk14 |
| nuclear factor, erythroid derived 2, like 2 | Nfe2l2 |
| protein kinase C, alpha | Prkca |
| protein kinase C, beta 1 | Prkcb1 |
| v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G | Mafg |
| v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K | Mafk |
| dynamin 1 | Dnm1 |
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 1 | Gabra1 |
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 | Gabra3 |
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 | Gabra4 |
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 | Gabra5 |
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 | Gabra6 |
| gamma-aminobutyric acid receptor associated protein | Gabarap |
| Gephyrin | Gphn |
| N-ethylmaleimide sensitive fusion protein | Nsf |
| Rous sarcoma oncogene | Src |
| ubiquilin 1 | Ubqln1 |
Figure 1Gene expression analysis by real time RT-PCR of similar to C11orf17 protein (RGD1306959), caveolin 3, enolase 3 and Hif-1 alpha genes in trained and control rats. Data are expressed as mean ± SE; p-values are referred to trained vs. control rats.
Figure 2Immunohistochemistry and western blot quantification of caveolin-3. Top: Left ventricle slides were obtained from frozen tissue by a cryotome and stained with anti caveolin-3 antibody, followed by HRP-conjugated secondary antibody and DAB reaction. One representative picture of cardiac tissue from controls and trained rats is shown. Immunohistochemistry images were analyzed by a software, which allowed the evaluation of the percentage of the area that reacted with anti caveolin-3 antibody. P-values are referred to trained vs. control rats. Bottom: Representative Western Blot assay with anti caveolin-3 antibodies. Bands of approximately 18 kDa correspond to caveolin 3 monomer. Cytoplasmic actin (43 kDa) was immunostained for equal loading control in the same gel. Lanes 1 to 4: protein extracted from left ventricle of control rats. M: markers. Lanes 5 to 8: protein extracted from left ventricle of exercise trained rats. The Western Blot was scanned by a densitometer and caveolin-3/actin ratio was found significantly larger in blots from trained rat hearts respect to controls.
Figure 3Fluorescence microscopy view of a longitudinal section of cardiomyocytes from a trained rat heart, double labeled with anti-caveolin 3 antibody (green) – staining the cell membranes – and anti-myosin heavy chain (red) – staining the sarcomers. Nuclei have been counter labeled in blue. Magnification: 400×.
Figure 4I/R experiments: A = images of a heart from control and mildly exercised rats: blue = perfused myocardium; red = area at risk; white = infarct tissue. B = mean percentages ± SE of myocardial risk areas at the end of 30 min-ischemia followed by 90 min-reperfusion and of infarct areas (values are representative of total ventricle percentage).